Bradford D Gessner

Summary

Country: France

Publications

  1. doi request reprint The case for a typhoid vaccine probe study and overview of design elements
    Bradford D Gessner
    Agence de Medecine Preventive, 13 Chemin du Levant, 01210 Ferney Voltaire, France Electronic address
    Vaccine 33:C30-5. 2015
  2. doi request reprint Vaccine preventable disease incidence as a complement to vaccine efficacy for setting vaccine policy
    Bradford D Gessner
    Agence de Medecine Preventive, 164 rue de Vaugirard, 75015 Paris, France Electronic address
    Vaccine 32:3133-8. 2014
  3. doi request reprint Vaccines as a tool to estimate the burden of severe influenza in children of low-resourced areas (November 30-December 1, 2012, Les Pensieres, Veyrier-du-Lac, France)
    Bradford D Gessner
    Agence de Médecine Préventive AMP, Paris, France
    Vaccine 31:3222-8. 2013
  4. doi request reprint Pneumococcal serotype distribution among meningitis cases from Togo and Burkina Faso during 2007-2009
    Bradford D Gessner
    Agence de Medecine Preventive, Paris, France
    Vaccine 30:G41-5. 2012
  5. doi request reprint Informing decision makers: experience and process of 15 National Immunization Technical Advisory Groups
    Bradford D Gessner
    Agence de Medecine Preventive, Paris, France
    Vaccine 28:A1-5. 2010
  6. pmc African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults
    Bradford D Gessner
    Agence de Medecine Preventive, 25 28 rue du Dr, Roux, Paris 75728, France
    BMC Infect Dis 10:22. 2010
  7. pmc Pneumococci in the African meningitis belt: meningitis incidence and carriage prevalence in children and adults
    Judith E Mueller
    Agence de Medecine Preventive, Paris, France
    PLoS ONE 7:e52464. 2012
  8. pmc Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003
    Judith E Mueller
    Agence de Medecine Preventive, Paris, France
    Emerg Infect Dis 13:847-54. 2007
  9. doi request reprint Association of respiratory tract infection symptoms and air humidity with meningococcal carriage in Burkina Faso
    Judith E Mueller
    Agence de Medecine Preventive, Paris, France
    Trop Med Int Health 13:1543-52. 2008
  10. pmc Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso
    Isabelle Delrieu
    Agence de Medecine Preventive, Paris, France
    PLoS ONE 6:e19513. 2011

Collaborators

Detail Information

Publications33

  1. doi request reprint The case for a typhoid vaccine probe study and overview of design elements
    Bradford D Gessner
    Agence de Medecine Preventive, 13 Chemin du Levant, 01210 Ferney Voltaire, France Electronic address
    Vaccine 33:C30-5. 2015
    ..The primary outcome would be the vaccine preventable disease incidence of prolonged fever hospitalization. Sample size calculations suggest that such a study would be feasible over a reasonable set of assumptions. ..
  2. doi request reprint Vaccine preventable disease incidence as a complement to vaccine efficacy for setting vaccine policy
    Bradford D Gessner
    Agence de Medecine Preventive, 164 rue de Vaugirard, 75015 Paris, France Electronic address
    Vaccine 32:3133-8. 2014
    ..We recommend that VPDI be incorporated along with VE into the analytic plans of vaccine trials, as well as decisions by funders, ministries of health, and regulatory authorities. ..
  3. doi request reprint Vaccines as a tool to estimate the burden of severe influenza in children of low-resourced areas (November 30-December 1, 2012, Les Pensieres, Veyrier-du-Lac, France)
    Bradford D Gessner
    Agence de Médecine Préventive AMP, Paris, France
    Vaccine 31:3222-8. 2013
    ..Should countries implement this strategy, infants age 6-23 months likely would remain at increased risk; vaccine probe approaches could quantify the public health benefit of immunizing this group. ..
  4. doi request reprint Pneumococcal serotype distribution among meningitis cases from Togo and Burkina Faso during 2007-2009
    Bradford D Gessner
    Agence de Medecine Preventive, Paris, France
    Vaccine 30:G41-5. 2012
    ..Pneumococcal meningitis was highly seasonal regardless of serotype. Data from this study emphasize the potential usefulness of PCVs among older children and adults...
  5. doi request reprint Informing decision makers: experience and process of 15 National Immunization Technical Advisory Groups
    Bradford D Gessner
    Agence de Medecine Preventive, Paris, France
    Vaccine 28:A1-5. 2010
    ..Individual country authors identified numerous areas for improvement and these are summarized here...
  6. pmc African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults
    Bradford D Gessner
    Agence de Medecine Preventive, 25 28 rue du Dr, Roux, Paris 75728, France
    BMC Infect Dis 10:22. 2010
    ..We aimed to collect all available population based data on pneumococcal meningitis throughout life in the African meningitis belt and then to model overall meningitis risk to help inform vaccine policy...
  7. pmc Pneumococci in the African meningitis belt: meningitis incidence and carriage prevalence in children and adults
    Judith E Mueller
    Agence de Medecine Preventive, Paris, France
    PLoS ONE 7:e52464. 2012
    ..The development of optimal vaccination strategies for pneumococcal conjugate vaccines requires serotype-specific data on disease incidence and carriage prevalence. This information is lacking for the African meningitis belt...
  8. pmc Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003
    Judith E Mueller
    Agence de Medecine Preventive, Paris, France
    Emerg Infect Dis 13:847-54. 2007
    ..These findings show the need for large samples and a longitudinal design for N. meningitidis serogroup A carriage studies...
  9. doi request reprint Association of respiratory tract infection symptoms and air humidity with meningococcal carriage in Burkina Faso
    Judith E Mueller
    Agence de Medecine Preventive, Paris, France
    Trop Med Int Health 13:1543-52. 2008
    ..To evaluate risk factors for meningococcal carriage and carriage acquisition in the African meningitis belt, comparing epidemic serogroup A (NmA) to non-epidemic serogroups...
  10. pmc Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso
    Isabelle Delrieu
    Agence de Medecine Preventive, Paris, France
    PLoS ONE 6:e19513. 2011
    ..Although limited to a few districts, we have documented NmX meningitis epidemics occurring with a seasonal incidence previously only reported in the meningitis belt for NmW135 and NmA, which argues for development of an NmX vaccine...
  11. pmc Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage, and immunity
    Judith E Mueller
    Agence de Medecine Preventive, Paris, France
    J Infect Dis 204:1787-95. 2011
    ..To better understand localized meningococcal meningitis epidemics, we evaluated a serogroup A (NmA) epidemic in Burkina Faso by surveillance, carriage, and seroprevalence studies...
  12. doi request reprint Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia
    Bradford D Gessner
    Agence de Medecine Preventive, Institut Pasteur, Paris, France
    Pediatr Infect Dis J 27:438-43. 2008
    ..Most of Asia, including Indonesia, does not use Haemophilus influenzae type b (Hib) conjugate vaccines. We estimated total vaccine-preventable disease burden and the cost-effectiveness of Hib conjugate vaccine in Indonesia...
  13. doi request reprint Haemophilus influenzae type b vaccine impact in resource-poor settings in Asia and Africa
    Bradford D Gessner
    Agence de Medecine Preventive, 25 rue du Dr Roux, 75724 Paris Cedex 15, France
    Expert Rev Vaccines 8:91-102. 2009
    ..Future issues include monitoring for serotype replacement and the effects of the HIV epidemic, evaluating the usefulness of a booster dose or new vaccine schedules and working to lower vaccine prices...
  14. ncbi request reprint Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines
    Judith E Mueller
    Agence de Medecine Preventive, 25 du Dr Roux, 75724 Paris Cedex 15, France
    Expert Rev Vaccines 5:319-36. 2006
    ..This review summarizes the existing data on N. meningitidis W135 epidemiology, immunology and vaccines as they relate to meningitis in sub-Saharan Africa...
  15. doi request reprint The impact of vaccines on pneumonia: key lessons from Haemophilus influenzae type b conjugate vaccines
    Bradford D Gessner
    Agence de Medecine Preventive, Institut Pasteur, 28 rue du Doctor Roux, F 75724 Paris, France
    Vaccine 26:B3-8. 2008
    ....
  16. doi request reprint A hypothetical explanatory model for meningococcal meningitis in the African meningitis belt
    Judith E Mueller
    Agence de Medecine Preventive, Institut Pasteur, 25 28 Rue du Dr Roux, 75724 Paris Cedex 15, France
    Int J Infect Dis 14:e553-9. 2010
    ..Epidemic waves occur if new meningococcal strains which escape pre-existing immunity, enter the population. Future research should include the impact of viral co-infection on bacterial colonization and invasion...
  17. ncbi request reprint Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003
    Judith E Mueller
    Agence de Medecine Preventive, Paris, France
    J Infect Dis 193:812-20. 2006
    ..meningitidis serogroup W-135 and serogroup A disease are hyperendemic and most of the population received polysaccharide A/C vaccine during 2002...
  18. pmc Mobile microbiological laboratory support for evaluation of a meningitis epidemic in Northern Benin
    Berthe Marie Njanpop-Lafourcade
    Agence de Medecine Preventive, Paris, France
    PLoS ONE 8:e68401. 2013
    ..Fixed laboratory capacity in Africa may be inadequate; mobile microbiological laboratories may address this issue but their utility has seldom been evaluated...
  19. doi request reprint Establishment of a National Immunization Technical Advisory Group in Côte d'Ivoire: process and lessons learned
    Julia Blau
    Agence de Medecine Preventive, s c Institut Pasteur, 25 28 Rue du Docteur Roux, 75724 Paris Cedex 15, France
    Vaccine 30:2588-93. 2012
    ..The latter rapidly dissolved over the course of numerous meetings held with the SIVAC Initiative to clarify the mandate of a NITAG...
  20. ncbi request reprint Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing
    Isabelle Parent Du Chatelet
    Association pour l Aide a la Medecine Preventive, Institut Pasteur, Paris, France
    Clin Infect Dis 40:17-25. 2005
    ..The improved ability to identify the etiologic agent in cases of bacterial meningitis will facilitate more rapid administration of precise therapy...
  21. doi request reprint Global incidence of serogroup B invasive meningococcal disease: a systematic review
    Shruti Sridhar
    Agence de Medecine Preventive, Ferney Voltaire, France
    Lancet Infect Dis 15:1334-46. 2015
    ..The low availability of data from low-income and middle-income countries suggests the need for improved surveillance before vaccination strategies are designed...
  22. doi request reprint Budget process bottlenecks for immunization financing in the Democratic Republic of the Congo (DRC)
    Jean Bernard Le Gargasson
    Agence de Medecine Preventive, Paris, France Electronic address
    Vaccine 32:1036-42. 2014
    ..DRC has introduced a series of reforms to move the country toward performance-based management and program budgets...
  23. doi request reprint Determinants of routine immunization costing in Benin and Ghana in 2011
    Césaire Damien Ahanhanzo
    Agence de Médecine Préventive AMP, Ferney Voltaire, France
    Vaccine 33:A66-71. 2015
    ..Existing tools to evaluate costs do not always capture the heterogeneity of costs at the facility level. This study seeks to address this issue through an analysis of determinants of health facility immunization costs...
  24. doi request reprint Costs of routine immunization and the introduction of new and underutilized vaccines in Ghana
    Jean Bernard Le Gargasson
    Agence de Medecine Preventive, Paris, France Electronic address
    Vaccine 33:A40-6. 2015
    ..Given their high price, it would be beneficial to Ghanaian health authorities to know the true cost of their introduction...
  25. doi request reprint Supporting countries in establishing and strengthening NITAGs: lessons learned from 5 years of the SIVAC initiative
    Alex Adjagba
    Agence de Medecine Preventive, 164 rue de Vaugirard, 75015 Paris, France Electronic address
    Vaccine 33:588-95. 2015
    ..These should be done through the development and dissemination of tools and guidelines, and information through a variety of adapted mechanisms. ..
  26. doi request reprint Costs for households and community perception of meningitis epidemics in burkina faso
    Anaïs Colombini
    Agence de Medecine Preventive, Ferney Voltaire, France
    Clin Infect Dis 49:1520-5. 2009
    ..Preventive immunization against meningitis will overcome limitations imposed by traditional beliefs and contribute to poverty reduction goals...
  27. ncbi request reprint Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial
    Bradford D Gessner
    Association pour l Aide a la Medecine Preventive, Paris, France
    Lancet 365:43-52. 2005
    ..Whether Hib disease truly is rare or whether many cases remain undetected is unclear...
  28. doi request reprint Meningococcal Seroepidemiology 1 Year After the PsA-TT Mass Immunization Campaign in Burkina Faso
    Haoua Tall
    Agence de Medecine Preventive, Paris, France
    Clin Infect Dis 61:S540-6. 2015
    ..This study describes specific antibody titers in the general population 11 months later and compares them to preintroduction data obtained during 2008 using the same protocol...
  29. doi request reprint From current vaccine recommendations to everyday practices: An analysis in five sub-Saharan African countries
    Isabelle Delrieu
    Agence de Medecine Preventive, 164 rue de Vaugirard, 75015 Paris, France Electronic address
    Vaccine 33:7290-8. 2015
    ..We estimated the reported age at vaccination, and vaccine coverage at different ages in children from five sub-Saharan African countries...
  30. doi request reprint A systematic literature review of missed opportunities for immunization in low- and middle-income countries
    Shruti Sridhar
    Agence de Medecine Preventive, 164 rue de Vaugirard, Paris 75015, France Electronic address
    Vaccine 32:6870-9. 2014
    ..Missed opportunities for immunization (MOIs) may contribute to low coverage in diverse settings, including developing countries...
  31. doi request reprint Design of a Phase III cluster randomized trial to assess the efficacy and safety of a malaria transmission blocking vaccine
    Isabelle Delrieu
    Agence de Medecine Preventive, 13 Chemin du Levant, 01210 Ferney Voltaire, France Electronic address
    Vaccine 33:1518-26. 2015
    ..Sample size estimates suggest that such a trial is feasible, and within the range of previously supported trials of malaria interventions, although substantial issues to implementation exist. ..
  32. doi request reprint Cholera outbreaks in Africa
    Martin A Mengel
    Agence de Medecine Preventive, 164 rue de Vaugirard, 75015, Paris, France
    Curr Top Microbiol Immunol 379:117-44. 2014
    ....
  33. doi request reprint Seasonal influenza epidemiology in sub-Saharan Africa: a systematic review
    Bradford D Gessner
    Agence de Medecine Preventive, Paris, France
    Lancet Infect Dis 11:223-35. 2011
    ....